You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 60.4% | 38.2% |
| ROCE | 126.9% |
| Latest | Forecast | |
|---|---|---|
| P/E | 2.2 | 740.4 |
| PEG | 0.0 | -0.1 |
| Price / Revenue | 1.1 | 2.8 |
| Price / Book value | 2.0 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 2,316.7% | -67.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | -83.8% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (€m) |
Pre-tax (€m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | 11.08 | -5.71 | €-0.47 | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | 12.75 | -3.49 | €-0.15 | -4.4 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | 13.72 | -2.08 | €-0.06 | -6.2 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 11.47 | -3.43 | -8.00p | -1.6 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | 277.20 | 165.17 | 194.00p | 4.4 | 0.0 | n/a | n/a | 0.0% |
| Novacyt gets UK approval for 'genesig' Covid-19 test Sharecast News | 26 Nov |
|---|---|
| Novacyt flags possible £3m hit from Covid test regulations change Sharecast News | 02 Nov |
| Novacyt launches new 'Winterplex' test, lateral flow tests delayed Sharecast News | 30 Sep |
| Approval of COVID-19 test under CTDA legislation | 26-Nov-21 07:00 |
|---|---|
| Validation of COVID-19 tests in the UK under CTDA | 02-Nov-21 07:00 |
| Liquidity Agreement and Total Voting Rights | 01-Nov-21 17:30 |
| Results of annual general meeting | 19-Oct-21 16:15 |
| Total Voting Rights | 01-Oct-21 14:30 |